Cargando…
Despite Affordability, Low Utilization of Lipid Lowering Drugs in Iran: Trend Analysis and Benchmarking 2005-2016
Dyslipidemia is responsible for great mortality and morbidity each year. Little data are available on the availability and affordability of Dyslipidemia medications in low and middle incomes countries. In a retrospective time-series study, we examined the utilization pattern and affordability of lip...
Autores principales: | Zartab, Saman, Abbassian, Hadi, Nassiri Koopaei, Nasrin, Hajimolaali, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706728/ https://www.ncbi.nlm.nih.gov/pubmed/31531093 http://dx.doi.org/10.22037/ijpr.2019.1100695 |
Ejemplares similares
-
The impact of sanction and healthcare system reform on the healthcare performance and pharmaceutical market in Iran; 2001-2016
por: Zartab, Saman, et al.
Publicado: (2020) -
Antibiotic Utilization in Iran 2000–2016: Pattern Analysis and Benchmarking with Organization for Economic Co-operation and Development Countries
por: Abbasian, Hadi, et al.
Publicado: (2019) -
Trend Analysis of Medicine Consumption Based on Therapeutic Categories in Iran: 2000–2016
por: Yektadoost, Alireza, et al.
Publicado: (2018) -
Low utilisation of diabetes medicines in Iran, despite their affordability (2000–2012): a time-series and benchmarking study
por: Sarayani, Amir, et al.
Publicado: (2014) -
Trend analysis of the pharmaceutical market in Iran; 1997–2010; policy implications for developing countries
por: Kebriaeezadeh, Abbas, et al.
Publicado: (2013)